In the GSE25066 and TCGA2 dataset, DDX39 expression was significantly higher in subtypes of Luminal B, Her2-positive, and basal-like BC, which were known as the molecular subtypes with the poorest prognosis (P<0.01) (Fig. 2B). This evidence concerns the gene DDX39A and breast cancer.